Cirtec Medical
Generated 5/9/2026
Executive Summary
Cirtec Medical is a specialized contract design, development, and manufacturing organization (CDMO) serving the medical device and drug delivery markets. Founded in 1984 and based in Lowell, Massachusetts, the company offers end-to-end engineering and manufacturing solutions for complex Class II and III devices. Its core capabilities include precision metals, advanced electronics, catheter technologies, and silicone/elastomer components. By providing comprehensive support from concept through commercialization, Cirtec helps clients accelerate time-to-market and reduce costs. The company has established itself as a reliable partner in the highly regulated medical device industry, leveraging decades of experience to address the growing demand for outsourced manufacturing and design services. As a private entity, Cirtec is positioned to capitalize on the expanding CDMO market, driven by increasing device complexity and cost pressures on medical device firms. The company's emphasis on complex devices aligns with industry trends toward miniaturization, connectivity, and drug-device combinations. While financial details are not publicly disclosed, Cirtec's long history and specialized expertise suggest a stable and growing business. Key risks include customer concentration and regulatory changes, but the overall outlook remains positive given the secular shift toward outsourcing in medtech.
Upcoming Catalysts (preview)
- Q4 2026New manufacturing facility expansion to increase capacity70% success
- Q2 2027Strategic partnership with a large medical device OEM50% success
- Q3 2026Client FDA approvals for devices manufactured by Cirtec60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)